Ibrutinib dose and clinical outcome in chronic lymphocytic leukemia - learning from the ‘real world’

Prithviraj Bose; Lisa S. Chen; Varsha Gandhi

doi:10.1080/10428194.2019.1571207

Ibrutinib dose and clinical outcome in chronic lymphocytic leukemia - learning from the ‘real world’

Prithviraj Bose, Lisa S. Chen, Varsha Gandhi

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1603-1605
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	60
Issue number	7
DOIs	https://doi.org/10.1080/10428194.2019.1571207
State	Published - Jun 7 2019

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1080/10428194.2019.1571207

Cite this

@article{bb43a11f376e44c6ad8c15f3382143f9,

title = "Ibrutinib dose and clinical outcome in chronic lymphocytic leukemia - learning from the {\textquoteleft}real world{\textquoteright}",

author = "Prithviraj Bose and Chen, {Lisa S.} and Varsha Gandhi",

year = "2019",

month = jun,

day = "7",

doi = "10.1080/10428194.2019.1571207",

language = "English (US)",

volume = "60",

pages = "1603--1605",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "7",

}

TY - JOUR

T1 - Ibrutinib dose and clinical outcome in chronic lymphocytic leukemia - learning from the ‘real world’

AU - Bose, Prithviraj

AU - Chen, Lisa S.

AU - Gandhi, Varsha

PY - 2019/6/7

Y1 - 2019/6/7

UR - http://www.scopus.com/inward/record.url?scp=85061312909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061312909&partnerID=8YFLogxK

U2 - 10.1080/10428194.2019.1571207

DO - 10.1080/10428194.2019.1571207

M3 - Comment/debate

C2 - 30724681

AN - SCOPUS:85061312909

SN - 1042-8194

VL - 60

SP - 1603

EP - 1605

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 7

ER -

Ibrutinib dose and clinical outcome in chronic lymphocytic leukemia - learning from the ‘real world’

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this